MRNA Jul 2024 162.500 call
| Previous Close | 0.0100 |
| Open | 0.0100 |
| Bid | 0.0100 |
| Ask | 0.9800 |
| Strike | 162.50 |
| Expire Date | 2024-07-26 |
| Day's Range | 0.0100 - 0.0100 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 11 |
ACCESSWIREModerna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a project award of $176 million through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines. ...
Barrons.comModerna Gets $176 Million From the U.S. to Make a Bird Flu Vaccine
Scientists have long worried about the potential pandemic threat posed by the virus. Three humans in the U.S. have been infected during the current outbreak.
BloombergUS Inks Vaccine Deal With Moderna as Bird Flu Threat Looms
(Bloomberg) -- Moderna Inc. secured nearly $200 million from the US government to speed development of an mRNA vaccine for pandemic influenza as a dangerous strain of bird flu sweeps through the nation’s dairy farms, fueling concern about a budding health crisis. Most Read from BloombergDemocrats Weigh Mid-July Vote to Formally Tap Biden as NomineePowerful Hurricane Beryl Aims at Jamaica After Grenada StrikeTrump Immunity Ruling Means Any Trial Before Election Unlikely‘Upflation’ Is the New Reta
